cb-012
caribou,crispr
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'cb-012', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'caribou', 'crispr']
today at the 2023 annual meeting, we presented preclinical data supporting evaluation of cb-012, our 3rd allogeneic car-t cell therapy program, for the treatment of adult patients with r/r #aml #aacr2023
#cartcelltherapy #crispr 
Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases